Lyons, M. J.; Bar, J. L.; Panizzon, M. S.; Toomey, R.; Eisen, S.; Xian, H.; and Tsuang, M. T., ,"Neuropsychological consequences of regular marijuana use: A twin study. " Psychological Medicine.34,7. 1239-1250. (2004. Results of previous research examining long-term residual effects of marijuana use on cognition are conflicting. A major methodological limitation of prior studies is the inability to determine whether differences between users and non-users are due to differences in genetic vulnerability preceding drug use or due to the effects of the drug.
INTRODUCTION
A recent meta-analysis of research relating to the residual neuropsychological effects of marijuana use found no evidence for significant long-term effects of the drug on neurocognitive processes ; however, the authors noted that many of the studies included in the analysis had significant methodological shortcomings that limited the generalizability of the findings (Grant et al. 2003 ). An earlier qualitative review by the same group concluded that most studies were too fraught with methodological flaws to provide clear evidence as to the nature of the effect (Gonzalez et al. 2002) . Among those studies reviewed, 55% found evidence for subtle cognitive impairments in marijuana users, ranging across a variety of specific neuropsychological domains. The most striking finding, however, was that of the 40 studies included in the survey, only 13 were able to meet all of the seven minimal methodological requirements articulated by the authors. These included the utilization of a control group, controlling for a history of neurological or psychiatric disorders, and the establishment of an abstinence period before neuropsychological testing. An earlier literature review reached a similar conclusion and argued for the use of more sophisticated research designs, as well as wide-ranging assessment batteries (Pope et al. 1995) .
While several studies have been conducted with more sound methodologies, findings are inconsistent regarding the extent of the longterm cognitive impairments associated with marijuana use. Solowij et al. (2002) found evidence for memory and attention impairments in long-term marijuana users compared to non-using controls after a minimum 12-hour abstinence period. Pope et al. (2002) found similar memory impairments up to 7 days after marijuana use ceased, but were unable to find a significant difference between users and controls after 28 days of abstinence. Other studies provide mixed evidence regarding residual neuropsychological deficits resulting from marijuana use (Mendhiratta et al. 1988; Schwartz et al. 1989 ; Solowij et al. 1991 ; Lyketsos et al. 1999 ; Varma et al. 2000) . Where differences between users and non-users have been found, they are often on only one or two tests out of a large number administered ; moreover, the differences are often modest, and users' scores are usually within the range of normal cognitive variability (Block & Ghoneim, 1993) .
The present study compares monozygotic twin pairs, who are discordant for regular marijuana use, on a broad spectrum of neuropsychological tests. Such a design has been referred to repeatedly in the literature as an ideal way of assessing the neuropsychological effects of marijuana while controlling for cognitive deficits that could be related to an underlying genetic vulnerability to substance use (Pope et al. 1995 ; Gonzalez et al. 2002 ; Grant et al. 2003) . Since monozygotic twins share 100% of their genes and many of the same childhood environmental experiences, this design can control for many of the confounding factors that have made previous results inconclusive.
METHOD Participants
Study participants were members of the Vietnam Era Twin (VET) registry. The registry, assembled from a Department of Defense computer file of 5 . 5 million veterans, comprises male-male twin pairs born between 1939 and 1957 in which both members served in the military during the Vietnam War era (1965) (1966) (1967) (1968) (1969) (1970) (1971) (1972) (1973) (1974) (1975) . Twin siblings were identified by matching veterans for same last name, date of birth and similar social security number, and confirmed by examination of military service records. Zygosity was assigned using responses to a series of questions about similarity of physical appearance, supplemented with blood group typing information. A complete description of registry construction (Eisen et al. 1987) , characteristics of registry members (Henderson et al. 1990) , and method of zygosity determination (Eisen et al. 1989) have been provided in detail elsewhere.
Drug use data collected previously by our group in the course of the Harvard Twin Study of Drug Abuse and Dependence were available from 1806 pairs of identical twins from the VET registry (Tsuang et al. 2001) . Participants were interviewed by telephone using the Diagnostic Interview Schedule, Version III -Revised (DIS-III-R ; Robins et al. 1988 ). This permitted lifetime psychiatric diagnoses to be made for a wide variety of disorders according to the Diagnostic and Statistical Manual for Mental Disorders, Third Edition Revised criteria (DSM-III-R ; APA, 1987) . Using these data, 117 monozygotic twin pairs (234 individuals) were identified who met the following criteria : (1) one twin used marijuana at least once weekly for a minimum of 1 year, while his co-twin never used marijuana more than five times in his life ; (2) the marijuana-using twin reported not using marijuana for at least 1 month prior to the DIS-III-R telephone interview ; (3) neither sibling reported regularly using, at least once weekly, any other illicit drug ; and (4) neither sibling reported ever experiencing symptoms of alcohol withdrawal (e.g. 'shakes ', difficulty sleeping, feeling anxious or depressed, sweating, rapid heart beat, delirium tremens, hallucinations, seizures). Twin pairs in which either one or both siblings reported alcohol withdrawal symptoms were excluded because of concern that the adverse health consequences associated with very heavy alcohol use might complicate the attempt to identify the adverse effects of marijuana (Fadda & Rossetti, 1998) .
Recruitment letters were mailed in 1995 to eligible members of the VET Registry. The 62 twin pairs who agreed to be examined were offered the opportunity to travel to one of two research sites, Boston (Harvard University) or St Louis (Washington University), or the option of having a research assistant travel to their hometown for an evaluation at a local hotel. Travel and hotel costs associated with participation were paid by the study, and $225 compensation was offered. Before the in-person evaluation, a research assistant explained the research procedures and obtained written informed consent. This method of consent was approved by all appropriate institutional review boards.
In total, data from eight twin pairs were eliminated from the analysis for the following reasons. Five twin pairs were removed because one sibling had used marijuana within the preceding 12 months. Another pair was excluded because one member had been misclassified as a non-user. One pair was excluded because one of the twins had experienced a stroke and had been treated for it surgically. A final pair was excluded because one of the twins had AIDS and a history of a psychotic illness. The present investigation, therefore, utilized data from 54 twin pairs.
Measures

Past marijuana use
The minimum number of days on which marijuana was used during the participant's lifetime was derived from responses to the following DIS-III-R questions administered in 1992: 'Have you ever used marijuana (hashish, bhang, ganja) ? ' 'Have you ever used marijuana (hashish, bhang, ganja) more than five times ?' 'Have you ever used marijuana (hashish, bhang, ganja) regularly, that is, once a week or more ? ' 'How many days per week did you use marijuana during your period of most frequent use ?' 'How old were you when you started your period of most frequent use? ' 'How old were you when you ended your period of most frequent use ?' and ' What was the longest period that you used marijuana almost every day? '
The minimum number of days on which marijuana was used was the greater of the following calculations : (a) number of days per week marijuana was used during the period of most frequent use multiplied by the number of weeks that period lasted, or (b) the total number of weeks of regular marijuana use, assuming one use per week. Days of marijuana use between 1992 and the present study, 1995-1996, were added to the minimum number of days used.
Neuropsychological tests
Participants were administered a comprehensive neuropsychological test battery by a research assistant blind to the twin's drug use history. Neuropsychological tests were chosen to assess the following cognitive domains : general intelligence, attention, memory, executive functioning and motor skills. (Wechsler, 1981) . This domain also included a measure of general nonverbal problem solving as assessed by the number correct from the Raven's Advanced Progressive Matrices -Set I (Raven, 1982) ; and a measure of reading achievement as assessed by the standard score from the Wide Range Achievement Test -Revised (WRAT-R ; Jastak & Wilkinson, 1984) . Attention was assessed with the Cancellations Test time and organization scores of the visual attention and speed/random verbal and non-verbal conditions (Mesulam, 1985) ; Trail Making Test, time score for part A ; and the Continuous Performance Test (CPT), mean reaction time, number correct, omissions, number incorrect, omissions and sensitivity for both AX-and X-degraded conditions (Rosvold et al. 1956; Davies & Parasuraman, 1982) . The memory domain was assessed with the Wechsler Memory Scale -Revised (WMS-R), recall for the immediate and delayed conditions of the Logical Memory and Visual Reproductions subtests (Wechsler, 1987) ; the California Verbal Learning Test (CVLT), list A total trials 1-5, short delay free and cued recall, long delay free and cued recall, and recognition hits (Delis et al. 1987) ; and the Rey-Osterrieth Complex Figure Test , accuracy scores for the copy, immediate and delayed recall conditions (Rey, 1941 ; Osterrieth, 1944) . Executive functioning was assessed with the Wisconsin Card Sorting Test (WCST), number of categories and perseverative errors (Heaton, 1981) ; the Stroop Test, age-corrected T score for the Color/Word condition (Stroop, 1935) ; Trail Making Test, time score for part B -part A ; and the ReyOsterrieth Complex Figure Test , organization score for the copy, immediate and delayed recall conditions (Rey, 1941; Osterrieth, 1944) . Finally, the motor skills domain was assessed by the Finger Tapping Test (FTT), the average number of taps across trials for the dominant and non-dominant hands (Halstead, 1947) ; and the Grooved Pegboard, time for the dominant and non-dominant hands (Matthews & Klove, 1964) .
Statistical analyses
Demographic differences between marijuana using and non-using twin pair members were examined using McNemar's x 2 test for paired proportions for dichotomous response variables, and the matched pairs t test for continuous variables. Intra-pair median differences of ordinal scale variables were evaluated using the Wilcoxon signed rank test. To assess for a nonresponse bias, data collected in 1992 from the 54 pairs who participated in the present study were compared with data from the 55 twin pairs who chose not to participate for differences in age, race, employment status, educational level, alcohol abuse/dependence status and marijuana days of use as of 1992. The two groups were also compared for the lifetime prevalence of the following psychiatric disorders : alcohol and nicotine abuse or dependence, mania, bipolar disorder, major depression, dysthymia, generalized anxiety disorder, pathological gambling and panic disorder.
To control for multiple tests, we took a sequential approach to comparing the marijuana users to their non-using co-twins. We first examined differences on the five neuropsychological domains between using and non-using twin-pair members using a multivariate approach with a repeated-measures general linear model. This model used each pair as a case and the two members of the pair as the withinsubjects factor. If the multivariate test of a neuropsychological domain was significant, we followed this with a univariate approach. First, we used the Kolmogorov-Smirnov test to determine whether the neuropsychological test scores were normally distributed. For those scores that were normally distributed, we compared groups using matched-pairs t tests. For those scores that were not normally distributed, we compared groups using the Wilcoxon signed rank tests. Within the user group, dose-response relationships between the number of days of marijuana use and neuropsychological test scores were examined using Pearson correlation coefficients for normally distributed variables and Spearman correlation coefficients for those that were not normally distributed. Significance levels were set at p<0 . 05 (two-tailed) for all analyses.
In order for the difference between marijuana users and non-users on a specific measure to be formally designated as ' significant', we required that the multivariate test of the domain achieve statistical significance and that the follow-up univariate test of the individual measure also achieve significance. Given the widespread a priori expectation that marijuana has adverse effects on cognitive functioning, we wanted to balance the risk of type I error (incorrectly concluding that marijuana users were significantly different from their non-using co-twins) with the risk of type II error (incorrectly concluding that marijuana users did not differ from their non-using co-twins). In general, a conservative scientific approach places a higher priority on the avoidance of type I error ; however, we wanted to balance this against the risk of missing actual differences that did exist and making a type II error. Therefore, we calculated the means and effect sizes along with the nominal statistical significance of every possible univariate test comparing marijuana using twins to their non-using co-twins.
We did not consider univariate tests to reach our criterion for statistical significance if the multivariate significance test of the domain to which they belong did not reach statistical significance. However, in the interest of providing readers with as much relevant information as possible, we chose to report the nominal probability of each univariate test. Because these values are not adjusted for the numerous comparisons that we conducted, we do not consider a probability below 0 . 05 to be statistically significant. These probabilities are presented for descriptive, not inferential, purposes. Our group has successfully used this method in a similar study of twins discordant for stimulant use (Toomey et al. 2003) .
RESULTS
At the time of neuropsychological assessment, participants' ages ranged from 38 to 51 years (mean=46 . 3¡3 . 1). Former marijuana users were not significantly different from their cotwins in the proportion who were currently married (users 79 . 2 %, non-users 81 . 5%; x 2 = 0 . 08, p=0 . 78) or employed (users 98 . 1 %, nonusers 94 . 4%; x 2 =1 . 0, p=0 . 31), and were in the same median household income bracket ($50,001-$60,000, Z=x0 . 93, p=0 . 35). Education level did not differ between the two groups (users 13 . 9 years, non-users 14 . 3 years, Z=x1 . 49, p=0 . 14), nor did the groups differ on indicators of learning problems in school such as being in a special school (0 users, 3 nonusers), being in a special academic class (users 11 . 1%, non-users 3 . 7%; x 2 =2 . 67, p=0 . 10), or getting special help for academic problems (users 14 . 8%, non-users 18 . 5%; x 2 =0 . 40, p=0 . 52). In the user group, no subject reported ever being diagnosed with a learning disability or with attention deficit disorder. In the nonuser group, one subject reported having been diagnosed with a learning disability and one subject reported having been diagnosed with attention deficit disorder. The groups did not differ in having ever had a head injury (users 53 . 7%, non-users 46 . 3%; x 2 =0 . 62, p=0 . 43). No significant differences were observed between former marijuana users and their nonusing co-twins in lifetime prevalence of alcohol abuse/dependence (users 63 . 0 %, non-users 51 . 9%; x 2 =1 . 64, p=0 . 20), total number of years drinking alcohol (users 24 . 1, non-users 23 . 9; t=0 . 14, p=0 . 89), proportion of current drinkers (users 74 . 0 %, non-users 69 . 2%; x 2 = 0 . 29, p=0 . 59), and average number of drinks per day during the preceding year among currently drinking twins (users 0 . 92, non-users 0 . 66; t=1 . 64, p=0 . 11). No significant differences were observed between former marijuana users and non-users in lifetime prevalence of Among the marijuana-using members of the 54 twin pairs, 37 % reported using marijuana a minimum of between 52 and 300 days during their lifetime, 39% a minimum of between 301 and 1000 days, and 24 % a minimum of between 1001 and 7000 days ( Table 2 ). The mean number of days on which marijuana was used was 916 (S.D.=1201). The mean age of initiating regular marijuana use was 21 . 3¡3 . 8 years (range= 17-38 years), of last regular marijuana use was 27 . 1¡6 . 0 years (range=19-43 years), and the mean duration of regular marijuana use was 5 . 8¡5 . 3 years (range=1-22 years).
As would be expected from previous twin research on cognitive abilities, we observed a substantial degree of resemblance within twin pairs (Cardon & Fulker, 1993) . Cross-twin correlations for the WAIS-R Full Scale (r=0 . 82), Verbal (r=0 . 79), Performance (r=0 . 74), and all 11 subtests (range=0 . 32-0 . 78) were significant at the p<0 . 01 level (except for Similarities and Picture Arrangement, which were significant at the p<0 . 05 level), as was the WRAT-R Reading standard score (r=0 . 83). Cross-twin correlations for WCST (range=0 . 38-0 . 42) and FTT (range=0 . 36-0 . 41) scores were all significant at the p<0 . 01 level. Correlations for three CVLT scores were significant at the p<0 . 01 level, two at the p<0 . 05 level, while two did not attain statistical significance (range=0 . 09-0 . 56). Table 3 presents the results from the multivariate analysis of the five cognitive domains. Of these domains, only general intelligence was found to differ significantly between marijuana users and non-users (F=1 . 968 ; p=0 . 045). Univariate analyses of the specific measures indicated that only one reached our criterion for statistical significance (Table 4 ). An inspection of univariate analyses in all of the domains indicated that very few had a nominal p value less than 0 . 05. Marijuana users performed significantly worse than non-users on the WAIS-R block design subtest (t=x1 . 97 ; p=0 . 05). The CVLT long delay free recall (t=x2 . 22; p= 0 . 03), and the average for the non-dominant # For variables that were normally distributed, paired-samples t tests were conducted and the t value was reported. For variables that were not normally distributed in either one or both groups, Wilcoxon signed rank tests were conducted, and the z value was reported.
hand on Finger Tapping (t=x2 . 11; p=0 . 04) did not meet our first criterion for significance, but did have nominal p values less than 0 . 05. Based on the nominal p values there was a 'trend ' (0 . 05<p<0 . 10) for users to perform worse than non-users on the CVLT long delay cued recall (t=x1 . 86; p=0 . 07). Also based on nominal p values, 'trends ' for users to perform better than non-users were observed for the WAIS-R performance IQ (t=1 . 76 ; p=0 . 09), the WAIS-R picture arrangement (t=1 . 84 ; p= 0 . 07), and the WRAT-R reading (t=1 . 71; p=0 . 09).
The correlation of total days of marijuana use and neuropsychological test performance (Table 5 ) revealed no significant dose response effects. Analysis of the distribution of scores for total days of marijuana use revealed one case to be a significant outlier from the rest of the sample (6188 marijuana use days; 4 S.D. above the mean). Inclusion of this case in the doseresponse analysis resulted in significant correlations with the number of correct responses (r=x0 . 29; p=0 . 03) and the number of omissions (r=0 . 31; p=0 . 02) on the CPT AX condition. The removal of this case from the doseresponse analysis resulted in non-significant correlations for the number of correct responses (r=0 . 036 ; p=0 . 798) and the number of omissions (r=x0 . 04 ; p=0 . 775) with marijuana use days.
DISCUSSION
We examined neuropsychological functioning in 54 male monozygotic twin pairs discordant for prior regular marijuana use. To address the risk of Type I errors, we first performed a small number of multivariate tests, comparing users and non-users on their performance across specific cognitive domains. Multivariate analysis yielded significant group differences on the general intelligence domain. We then examined group differences on individual subtests. Out of the 16 tests making up the general intelligence domain, marijuana users performed significantly worse than non-users on only the block design subtest of the WAIS-R. There was a trend in this domain for users to have a higher performance IQ than non-users as measured by the WAIS-R, a higher score on the picture arrangement subtest of the WAIS-R, and a higher reading standard score on the WRAT-R. Based on finding only one significant comparison between users and non-users on the tests comprising this domain, and the fact that there existed a trend of users performing better than non-users on several tests, we concluded that the effects observed in our multivariate analysis do not support the existence of meaningful long-term residual effects of regular marijuana use. The absence of any significant doseresponse relationship between the increased use of marijuana, as measured by the number of use days, and cognitive abilities further strengthens this conclusion. We considered the possible implications of the nominal p-values comparing users to nonusers on both the long delay free and cued recall conditions of the CVLT, the latter at the trend level. Previous studies found differences between heavy and light users on these two CVLT conditions, but also found differences on several other CVLT measures that failed to reach significance in our sample (Pope & YurgelunTodd, 1996) . Users, in our sample, performed no worse than non-users on the WMS-R Logical Memory II subtest, which assesses delayed recall for contextually meaningful verbal material.
Similarly, while the possibility of poorer performance on the FTT (non-dominant hand only) suggested by the nominal p value could be a sign of reduced manual dexterity, users performed equally well as non-users on the Grooved Pegboard, an even more complex and neurologically sensitive measure of motor dexterity and speed (Lezak, 1995) . The lack of supporting evidence for these cognitive deficits leads us to believe that, once again, our findings may simply reflect the large number of significance tests performed. Pope & Yurgelun-Todd (1996) , while acknowledging the large number of individual comparisons they made, nevertheless point out that almost every difference, whether significant or not, was in the direction of poorer performance by heavy users than by light users. This is not true of our results.
Given our failure to detect much in the way of differences between users and their co-twins, we considered the possibility that low statistical power could account for this. To evaluate this possibility, we examined the statistical power of our matched pairs t tests. One factor that influences the power of a matched pairs t test is the correlation within the pair. For the variables on which we conducted t tests, the within pair correlations ranged from a low of r=0 . 22 to a high correlation of r=0 . 83 with a mean correlation of r=0 . 50. Based on 54 pairs of twins, an alpha of 0 . 05, and Cohen's (1988) definitions of effect sizes, we calculated that for the variable with the lowest within pair correlation we had a power of 21 . 1 % to detect a small effect, a power of 82 . 4% to detect a medium effect, and a power of 99 . 6 % to detect a large effect. For the variable with the highest within pair correlation we had a power of 68 . 4% to detect a small effect and power greater than 99 % to detect a medium effect. For the average within pair correlation we had a power of 30 . 2 % to detect a small effect size, a power of 95 % to detect a medium effect, and a power of over 99% to detect a large effect. Thus, we do not believe that our failure to observe consistent differences between marijuana using twins and their non-marijuana using identical co-twins is likely to reflect inadequate statistical power. Real differences too small to be detected by our study are unlikely to have much practical importance.
These results are compatible with previous findings by our group, which found that a history of regular marijuana use was not associated with adverse effects on socio-demographic characteristics, physical health, or mental health (Eisen et al. 2002) , as well as those of other studies that found no, or few, differences between marijuana users and non-users on neuropsychological functioning. The research design used in the present study provides several methodological advantages over prior research on the cognitive effects of marijuana use. First, the sample is drawn from the VET registry, which is population-based. Many previous studies have used subjects obtained from treatment-seeking clinical samples (Gonzalez et al. 2002) . Individuals with cognitive impairment may be disproportionately represented among clinical groups, thus increasing the observed effects of marijuana use. Second, the use of monozygotic twins as controls minimizes the problem of confounding variables, such as premorbid differences in cognitive functioning, as monozygotic twins share all of their genes and many of the same childhood experiences. Third, the marijuana-using twin had smoked a considerable amount of marijuana. The mean number of days on which marijuana was used was 916 over a mean of 5 . 8 years, with 39% of users reporting a minimum of between 301 and 1000 days of use, and 24% reporting a minimum of between 1001 and 7000 days. Fourth, a minimum of 1 year had passed since the marijuana-using twin had last used the drug, and a mean of almost 20 years had passed since the last time marijuana had been used regularly. This precluded the possibility that positive results could be attributed to either a withdrawal effect or a drug residue effect. Any cognitive deficiencies observed could reasonably be attributed to a long-term CNS alteration effect. Finally, our study excluded twin pairs in which either member reported ever using any other illicit drug at least once weekly at any time in his life, or ever experienced symptoms of alcohol withdrawal. This reduced the likelihood that observed differences between twin siblings might be attributable to drugs other than marijuana.
Our study does have several potential limitations. First, because only about half of the eligible pairs participated in the study, it is possible that our results were influenced by nonresponse bias. Individuals whose functioning had been compromised by heavy marijuana use may have been unable or unwilling to participate. We attempted to examine this possibility by comparing 1992 data on the eligible pairs who did not participate to corresponding data from participating pairs. No differences were detected in age, race, employment status, educational attainment and a variety of psychiatric disorders. Nevertheless we cannot exclude the possibility that participation bias may have prevented us from detecting adverse effects of marijuana use on cognitive functioning.
Second, the assessment of regular marijuana use is based on retrospective self-report, and thus its validity is unknown. While the reliability and validity of self-reported drug use data have generally been demonstrated to be satisfactory (Brown et al. 1992 ; Harrison et al. 1993) , it is not known if this validity extends to recall of marijuana use patterns 20 years after regular use has ended. Similarly, although subjects denied recent substance use, we cannot be absolutely certain that some participants had not used drugs or alcohol in the days immediately prior to testing, leaving a possible drug residue in their bodies. Because of the possibility that marijuana-using twins might be more likely to use other substances, any drug residue effects might be more likely in the marijuana-using twin, biasing the results in the direction of greater impairment. Additionally, if the marijuana users had consumed in the past greater quantities of drugs other than marijuana that could produce more neuropsychological impairment among the marijuana users as a consequence of the other drugs. But the absence of impairment in the marijuana group reduces both of these concerns.
Third, it should be noted that the subjects in our sample by and large displayed moderate levels of marijuana use, and that our findings may not generalize to the effects brought on by very heavy marijuana use. Bolla et al. (2002) found evidence of neurocognitive deficits even after 4 weeks of abstinence in subjects who used marijuana as frequently as 13 times per day. Although we used a different method to determine the frequency of marijuana use, we can conclude that our sample did not approach this level of abuse. Our data, however, are probably more reflective of the typical marijuana user, and as such provide more generalizable results.
Fourth, although our design allows us to control for pre-existing differences in the family environment or genetic factors between regular marijuana users and non-users, it does not preclude the possibility that some environmental factor not shared by twins (e.g. an early childhood head injury) might increase the risk of future marijuana usage and produce neuropsychological impairment. This possibility of a third factor predisposing towards both marijuana usage and neuropsychological impairment independent of genetic and family environmental influences would be more of a concern if we had observed significant differences between the groups.
Fifth, our sample consisted entirely of males, and thus our results may not generalize to females. As women have been underrepresented in research on the consequences of drug abuse, and as Pope et al. (1997) found sex-specific residual effects of marijuana use on cognitive functioning, it is important to study marijuanausing women before conclusions can be drawn regarding the drug's effects.
Finally, a recent study by Pope et al. (2003) has provided evidence of a possible significant effect for early versus late onset marijuana use and subsequent cognitive deficits. Specifically, they found that individuals who began smoking marijuana before age 17 showed significant deficits when compared to those who began at age 17 or later. The authors hypothesize that this difference could be due to an innate cognitive deficit that predisposes an individual to begin using marijuana at an early age, a disruption in education brought on by the early use, or a neurotoxic effect of marijuana during early adolescence. In our sample only two subjects reported having tried marijuana before age 17, and none initiated regular marijuana use prior to that age. As a result, we were unable to separate our sample into early and late onset users, and could not appropriately address age of onset in our analyses. Therefore, if an innate cognitive impairment predisposes an individual to early but not late onset marijuana use, our study would not be able address this effect. The lack of early onset users in our sample could be the result of prior screening at the time of military induction, with early regular users being found unfit for military service.
Despite employing a rigorous research design, this study fails to find clear evidence in support of the hypothesis that regular marijuana use causes long-term residual CNS alternations. This suggests the need to study other illicit drugs whose regular use is assumed to have detrimental effects on long term-cognitive functioning.
